The recessive gene rymv-1 responsible for the high resistance of Oryza sativa cultivar Gigante to 19
Rice yellow mottle virus (Sobemovirus) was overcome by the variant CI4* which emerged after 20 serial inoculations of the non-resistance-breaking (nRB) isolate CI4. By comparison of the full-21 length sequences of CI4 and CI4*, we identified a non-synonymous mutation at position 1729 22 localised in the putative VPg domain and developed an assay based on this single nucleotide 23 polymorphism. The mutation G1729T was detected as early as the first passage in resistant plants 24 and was found in all subsequent passages. Neither reversion nor additional mutation were 25 observed. The substitution G1729T introduced by mutagenesis in the VPg of an nRB infectious 26 clone is sufficient to induce symptoms in non-inoculated leaves of cultivar Gigante. This is the 27 first evidence that VPg is a virulence factor in plants with recessive To correlate the presence of the mutation G1729T, detected in the sixth passage, and the RB 3 phenomenon, we developed a tool using a three-primer PCR method (Moravec et al., 2003) . Four 4 primers were designed to allow the detection of the RYMV polymorphism at position 1729 5 (Fig.1B) . The flanking primers F1 (nt 1469 to 1483, 5'-CCCCGCTCTACCACAA-3') and R1 6 (nt 2131 to 2117, 5'-AAAGATGACACCCGA-3') give a 663 bp fragment which constitutes a 7 positive marker of PCR in infected plants. Internal primer F2 (nt 1716 to 1729, 5'-8 TGGGTGCGTGAGAG-3') was designed to perfectly match the sequence of RYMV CI4 except 9 one mismatch (boldface) on the 3' end with the isolate CI4*. This primer, together with R1, gives 10 an additional band of 416 bp when a guanine is present at the position 1729. In contrast, the 11 internal primer R2 (nt 1741 to 1729, 5'-TGGTACCTCTCTA-3') matches the CI4* sequence, 12
giving with F1 an additional band of 273 bp when a thymine is present at the position 1729. To 13 perform the SNP detection, first strand synthesis was performed using Superscript II reverse 14 transcriptase (Gibco-BRL) with primer R1. The cDNA was used as template for PCR-15 amplification using DyNAzyme EXT DNA polymerase (Finnzymes) with the forward primer F1, 16 the reverse primer R1 and a third primer F2 or R2. In susceptible plants inoculated with CI4, only 17 the fragment of 416 bp was detected, indicating the presence of G1729 and the absence of T1729 18 (Fig.1C, lanes 1-2) . Inversely, after eight passages in resistant plants, only the fragment of 273 bp 19 was detected, indicating the absence of G1729 and the presence of T1729 (Fig.1C, lanes 7-8) . 20
Interestingly, the nucleotide T1729 was detected as early as the first passage while G1729 21 remained undetected (Fig.1C, lanes 3-4) . The nucleotide T1729 was retained at each subsequent 22 passage (data not shown). Therefore, only the isolates with a thymine at position 1729 were 23 detected in resistant plants. The non-mutated nucleotide G1729, whether derived from the initial 24 isolate CI4 or from a reversion, was never detected in resistant plants. After the first passage in 25 resistant plants, the isolate was back-inoculated to susceptible plants (Fig.1C , lanes 5-6). Again, 26 only the nucleotide T1729 was detected, indicating that an isolate containing the G1729T 27 mutation multiplied in susceptible plants. The same result was observed with the isolate CI4* 28 obtained after eight passages in resistant plants and back-inoculated to susceptible plants after 29 one or four serial passages (Fig.1C lanes 9-12) . This latter isolate infected resistant plants and 30 presented T1729 alone (Fig.1C, lanes 13-14) . Altogether, these results indicated that an isolate 31 containing the G1729T mutation was not counter-selected in susceptible plants and that this 32 isolate was still able to break the rymv-1 resistance. Again, the non-mutated nucleotide whether 33 derived from the initial isolate CI4 or from a reversion, was not detected in these susceptible 34 plants. Artificial mixed inoculations with CI4 and CI4* performed by Sorho et al. (2005) were 35 also assessed. The presence of T1729 was detected both in the susceptible and resistant plants 36 whereas G1729 was not detected in resistant plants, suggesting that there was no 37 complementation of nRB CI4 by RB CI4* (data not shown). 38
The mutation G1729T was detected at the first passage in resistant plants although no symptoms 39 were apparent. To determine whether the increasing intensity of the symptoms through passages 40 was due to additional mutations around G1729T, each isolate CI4* (obtained in resistant plants) 41 was partially sequenced from 1230 to 2090 nt with primers R9 (5'-42 ATAGGTGCTGCGGATGGTTA-3') and R10 (5'-GCTACGGGATGCGATGTCTC-3') after 43 PCR-amplification with the primers B S and B AS as described in (Fargette et al., 2004) . The 44 mutations C1298T, C1547T and G1729T were observed at each passage. The mutation G1544A 45 was never observed in the other CI4* isolates, suggesting it was not involved in resistance-46 breaking. No additional mutation was detected in the analysed fragment except G1489A at the 47 eighth passage. However, further serial passages in cv. Gigante did not reveal this mutation (data 1 not shown), indicating that this mutation was not stable. Moreover, the nucleotide G1489 is 2 conserved in the 16 isolates that have been fully sequenced. No additional mutation around 3 G1729T which could explain the appearance of symptoms was observed through serial passages. 4
However, after inoculation with leaf extracts of all previous passages and a longer symptom 5 monitoring, the appearance of mild symptoms from 45 dpi was observed (data not shown). As 6
shown by Sorho et al. (2005) , inoculum concentration is a key factor in overcoming resistance 7 which suggests that, in the previous experiment, the concentration was below the threshold to 8 produce symptoms at the first passages. 9
The mutation G1729T was introduced in a nRB infectious cDNA clone to validate its role in 10 resistance-breaking. As the clone of CI4 was not available, the infectious cDNA clone of the nRB 11 isolate CIa was used (Brugidou et al., 1995). Two PCR experiments were performed 12 independently with a flanking primer and a primer containing the mutation, FL5R5bis (nt 892 to 13 911, 5'-CCCGGGGTTACGTGGTTGAC-3') and RmIIR374I (nt 1739 to 1717, 5'-14 TACTTCGTTATCTCACGCACCC-3'), R14bis (nt 2424 to 2401, 5'-15 ACTTCGCCGGTTTCGCAGAGGATT-3') and FmIIR374I (nt 1714 to 1738, 5'-16 CCTGGGTGCGTGAGATAACGAAGTA-3'), respectively. The products of the two PCR 17 applications were mixed and used as template for another PCR experiment with the two flanking 18 primers. PCR fragment was cloned in the infectious cDNA clone CIa after double-digestion by 19
AflII and AvrII (Biolabs). The codon 1728-1730 AGG was mutated to ATA as in RB CI4* to 20 produce a clone called CIa*. The mutation was confirmed by sequencing the fragment. However, 21 two other mutations A1414G and G2095A were randomly introduced during the mutagenesis 22 process. The latter is localised at the ATG of ORF2b (Fig.1A) rymv-1 appears to be different from the well-studied eIF4E. We recently identified rymv-1 as a 9 truncated isoform of the eukaryotic translation initiation factor 4G (eIF(iso)4G) (Albar L, 10
Bangratz-Reiser M, Hébrard E, Njiondjop MN, Jones M, Ghesquière A, unpublished results). 11
The factors 4E and 4G and their isoforms provide different functions in the translation initiation 12 complex. While eIF4E binds directly to the cap of mRNA, the high molecular weight eIF4G acts 13 as a scaffold for other components of the complex such as eIF4E. Recently, eIF4G was reported 14 to be involved in recessive resistance against viruses of families Bromoviridae and 15
Tombusviridae ( were compared at each position and the number of sequences with the same nucleotide as CI4 or 6 CI4* were determined. 7 § Mutations which were only observed for CI4*. The name of each pair of primers and the size of each PCR-amplified fragments are indicated on 8 the right. F1 and R1 are external primers. F2 and R2 are specific for the presence of the wild-type 9 nucleotide G1729 and the mutated nucleotide T1729, respectively. (C) Detection of the mutation
